Abstract:The outbreak of coronavirus disease 2019 (COVID-19) has rapidly spread globally since being identified as a public health emergency of major international concern and has now been declared a pandemic by the World Health Organization (WHO). In December 2019, an outbreak of atypical pneumonia, known as COVID-19, was identified in Wuhan, China. The newly identified zoonotic coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is characterized by rapid human-to-human transmission. Many cancer patients frequently visit the hospital for treatment and disease surveillance. They may be immunocompromised due to the underlying malignancy or anticancer therapy and are at higher risk of developing infections. Several factors increase the risk of infection, and cancer patients commonly have multiple risk factors. Cancer patients appear to have an estimated twofold increased risk of contracting SARS-CoV-2 than the general population. With the WHO declaring the novel coronavirus outbreak a pandemic, there is an urgent need to address the impact of such a pandemic on cancer patients. This include changes to resource allocation, clinical care, and the consent process during a pandemic. Currently and due to limited data, there are no international guidelines to address the management of cancer patients in any infectious pandemic. In this review, the potential challenges associated with managing cancer patients during the COVID-19 infection pandemic will be addressed, with suggestions of some practical approaches. IMPLICATIONS FOR PRACTICE: The main management strategies for treating cancer patients during the COVID-19 epidemic include clear communication and education about hand hygiene, infection control measures, high-risk exposure, and the signs and symptoms of COVID-19. Consideration of risk and benefit for active intervention in the cancer population must be individualized. Postponing elective surgery or adjuvant chemotherapy for cancer patients with low risk of progression should be considered on a case-by-case basis. Minimizing outpatient visits can help to mitigate exposure and possible further transmission. Telemedicine may be used to support patients to minimize number of visits and risk of exposure. More research is needed to better understand SARS-CoV-2 virology and epidemiology.

Recommendations on Management of Gynecological Malignancies During the COVID-19 Pandemic: Perspectives from Chinese Gynecological Oncologists

[Management strategies for patients with gynecological malignancies during the outbreak of COVID19].

[Management strategies for three patients with gynecological malignancies during the outbreak of COVID-19].

Treatment and Prevention Strategies for Patients with Gynecological Malignancies During the COVID-19 Pandemic

Management of Gynecology Patients during COVID-19 Pandemic: Chinese Expert Consensus.

Management Of Gynecology Patients During The Coronavirus Disease 2019 Pandemic: Chinese Consensus

Challenges and countermeasures of thoracic oncology in the epidemic of COVID-19

Recommendation of radiotherapy for gynecological cancer during the COVID-19 epidemic

Clinical Considerations for the Management of Cancer Patients in the Mitigation Stage of the COVID-19 Pandemic.

A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: an International Collaborative Group.

Recommendations of individualized medical treatment and common adverse events management for lung cancer patients during the outbreak of COVID-19 epidemic.

Management of a delivery suite during the COVID-19 epidemic

Six Gynecological Cancer Patients Infected With SARS-CoV-2 After Surgery or Radio-/Chemo-Therapy Treatment: Case Series

Clinical Recommendations on Lung Cancer Management During the COVID‐19 Pandemic

Expert Consensus on the Management Process of Gynecological Emergency under the Regular Epidemic Prevention and Control of COVID-19

Strategies and recommendations for the management of gastrointestinal surgery during the COVID-19 pandemic: experience shared by Chinese surgeons

Practice of Surgical Treatment of Breast Cancer in China During the Novel Coronavirus COVID-19 Outbreak

Clinical Management of Lung Cancer Patients During the Outbreak of 2019 Novel Coronavirus Disease (COVID-19)

Gynecologic cancer surveillance in the era of SARS-CoV-2 (COVID-19)

The challenges in colorectal cancer management during COVID-19 epidemic

Chinese expert recommendations on management of hepatocellular carcinoma during COVID-19 pandemic: a nationwide multicenter survey